Joan Taltavull Moll

Title: Joan Taltavull Moll: Innovator in Pharmaceutical Chemistry

Introduction

Joan Taltavull Moll is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that target critical biological pathways.

Latest Patents

Joan holds five patents, showcasing her expertise and creativity in the pharmaceutical domain. Her latest patents include the development of 2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors. These new derivatives are disclosed along with processes for their preparation, pharmaceutical compositions comprising them, and their therapeutic use as inhibitors of Janus Kinases (JAK). Additionally, she has developed pyrrolotriazinone derivatives as PI3K inhibitors. These new derivatives, characterized by their unique chemical structure, are also accompanied by processes for their preparation, pharmaceutical compositions, and therapeutic applications as inhibitors of Phosphoinositide 3-Kinases (PI3Ks).

Career Highlights

Throughout her career, Joan has worked with notable companies such as Almirall, S.A. and Laboratorios Almirall, S.A. Her work in these organizations has allowed her to contribute to the advancement of pharmaceutical research and development.

Collaborations

Joan has collaborated with esteemed colleagues, including Lluis Miquel Pages Santacana and Francisco Javier Bernal Anchuela. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Joan Taltavull Moll is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of groundbreaking compounds. Her contributions continue to impact the field and pave the way for future innovations in therapy.